Quantitative receptor autoradiography was used to measure muscarinic cholinergic, benzodiazepine, kainate, phencyclidine (PCP) 
The traditional histopathological markers of Alzheimer's disease (AD), neurofibrillary tangles and senile plaques, are extremely prevalent in hippocampal formation. The density of plaques and tangles is highest in the entorhinal cortex which projects to the hippocampus via the perforant pathway, and in the CAl region and the subiculum which project to other cortical regions.' The prominent memory disorder seen in AD patients is probably due to this hippocampal pathology.
Neurotransmitter studies suggest that glutamic acid or a glutamate-like substance is the neurotransmitter of all long intrahippocampal connections: the perforant pathway to the molecular layers of the dentate gyrus and CA 1, the mossy fibre pathway from the dentate granule cells to the CA4 and CA3 regions of Ammon's horn, the Schaeffer collateral pathway from CA3 to CA1, and the CAI and subicular projection pathways.2 Glutamate is known to interact with at least four different excitatory amino acid neurotransmitter receptors: the N-methyl-D-aspartate (NMDA) receptor, the quisqualic acid receptor, the kainate receptor and the metabotropic receptor.'
The first three of these appear to regulate ion channels. All three are present in hippocampal formation.34 The NMDA and quisqualate receptors are important in memory formation as blockade of these receptors alters long term potentiation (LTP), a presumed physiological analogue of learning in animals. 7'0 There have been a number of studies of excitatory amino acid and other neurotransmitter receptors in the hippocampal formation of AD brains. These studies have employed a variety of techniques and have reported differing results. Serotonin receptors and GABAB receptors are significantly decreased in hippocampal formation. " 12 Some studies report decreases in muscarinic cholinergic recep- tors.'3 14 Others report little change in muscarinic or benzodiazepine receptors in the absence of significant cell loss.'5 16 No studies in Alzheimer's hippocampus have directly measured one neurotransmitter receptor using different methods or compared the changes to those of other receptors, to local pathology, or to similar measurements in other dementing illnesses. Therefore, we measured From each block, serial, 20 micron thick sections were obtained. Two were stained for neurofibrillary tangles with Congo red, two for acetylcholinesterase, and the rest were processed for receptor autoradiography as described in table 2. Table 2 details the buffers, washes and blanks used in the assays. All assays were carried out on triplicate sections. Because of the number of sections to be cut and the number of assays to be performed, not all the brains could be assayed on the same day, nor could all the assays be performed at the same time. Because we have found that the number of measurable glutamate, but not of other, receptors declines over days when sections are stored at -20°C, glutamate receptor assays were carried out on the day of sectioning. Therefore, the brains were divided into two groups with roughly equal numbers of each clinical diagnosis in each group. The sections from the first group of brains were obtained for the NMDA, muscarinic, benzodiazepine, kainate, Congo red and cholinesterase assays. The NMDA assay was carried out on the day of sectioning. The next day the second group was sectioned for the same assays and the NMDA assay carried out. The other assays were done on subsequent days. After these assays were performed, additional sections were obtained from the first group of blocks for the assays of total glutamate and non-quisqualate-sensitive glutamate binding in chloride buffer. These assays were then performed on the day of sectioning. The same procedure was then used to run the same two glutamate binding assays on the other group of brains.
Autoradiograms were generated by exposing the sections to Ultrofilm'H (LKB). Quantitative densitometry was performed blindly by observers who compared readings from the regions of interest to those from the standards containing known amounts of radioactivity.2"
The number of quisqualate displaceable binding sites was calculated by subtracting binding remaining in the presence of 2 5 jM quisqualate (NMC) from total glutamate bind- 
Results
There were no significant differences between the groups in their ages, postmortem delays or storage times in the freezer (table 1) . There was no significant effect on the results of performing the assays on different days. The number of neurofibrillary tangles found in a 20 x field of the various subregions of the hippocampal formation in the brains is shown in table 3. The regions examined for tangles were the granule cell layer of dentate gyrus, the pyramidal layers of regions CAI (SP1) and CA3 (CA3) of Ammon's horn, the subiculum (SUB) and the principal external layer of presubiculum (LPP). The Congo red staining revealed a wide range in the number of neurofibrillary tangles and senile plaques in the AD brains. Plaques and tangles were most common in subiculum and CAl.
Autoradiographic measurements of ligand binding were made in synaptic zones, including the molecular layers of dentate gyrus (DG) and CAI (SM 1), stratum pyramidale and (for kainate) stratum lucidum of CA3. Also, SP1, SUB, and LPP. Histograms showing the results of the measurements are shown in fig 1. Imageprocessing-computer generated pictures of muscarinic, benzodiazepine, PCP and NMDA binding to representative hippocampi are shown in fig 2. In the normal hippocampus, muscarinic binding was highest in SPI with high binding in SUB and DG. Benzodiazepine binding was highest in DG with slightly lower amounts in SP1 and the perihippocampal regions; there was very little benzodiazepine binding in CA3.
.so In SPI, binding of all the ligands, except quisqualate-sensitive glutamate binding, to Alzheimer's disease brains was significantly below control values. The percentages of decline from mean control binding levels was compared among the ligands using one-way ANOVA. A significant difference between the ligands was found (F6,63 = 3-010, p = 0-012).
In pairwise comparisons using the Duncan multiple range test, the declines in NMDA and non-quisqualate-sensitive binding were significantly greater than the muscarinic, benzodiazepine, quisqualate and kainate declines (p < 0-05 for each comparison). There were no other significant differences between pairs of ligands.
Discussion
The distribution of hippocampal binding was very similar for the different ligands with the exception of quisqualate and kainate. Binding was high in the synaptic zones of the dentate gyrus, CAl, subiculum and presubiculum. For most ligands it was highest in a broad band over stratum pyramidale of CAl. In humans this region contains the CAl pyramidal cell bodies and many of their apical and basal dendrites, thus corresponding to the strata pyramidale, radiatum and oriens of rodents.24 Quisqualatesensitive glutamate binding was high only in the dentate molecular layer. For kainate, binding was highest to stratum lucidum of CA3 and the inner portion of the dentate molecular layer.
The regions ofmedial temporal lobe with the largest degree of cell loss, neurofibrillary tangles and senile plaques in Alzheimer's disease are the entorhinal cortex (layers 2 and 4), CAl and subiculum.'21 Unfortunately, entorhinal cortex was not present on the sections removed from many of the brains examined in this study so no attempt was made to analyse data from that region. Although no direct measure of cell loss was made, the counts of tangles (table 3) suggests that the pathological severity in these brains ranged from mild to severe. The areas in which there were binding losses were generally those in which there was also the most marked pathology. Areas with severe pathology, however, did not always display receptor loss. The subiculum, for instance, had severe histological pathology but relatively little loss of excitatory amino acid binding. There were no significant losses in dentate gyrus and only muscarinic and benzodiazepine binding were down slightly in LPP.
The magnitude of the muscarinic and benzodiazepine binding changes found in these brains was similar to that found by Green 
